IIT Madras’s injectable hydrogel could reduce fibrosis treatment cost by 85%

Indian scientists develop AI-enabled tech for biomedical diagnostic applications

The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress

Quotient Sciences advances AI-designed drug product into Phase I clinical study

Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.

Tecan launches direct India operations

The move signals a major expansion milestone for the Swiss laboratory automation company

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.

Amgen appoints Madhur Sarin as Director – AI & Data Science COE

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform